Mark Dunne (PI), email@example.com
Funded by Innovate UK, this grant was awarded to the University of Manchester and Heptares Therapeutics to develop new molecules for the treatment of Congenital Hyperinsulinism.
Indi Banerjee, firstname.lastname@example.org
Funded by a MRC product innovation award to develop new therapeutic strategies for the treatment of Congenital Hyperinsulinism
Funded partly by Million Dollar Bike Ride Fund and Diabetes UK to investigate pathobiology of Congenital Hyperinsulinism